Importance of chronotherapy in arterial hypertension;Importancia de la cronoterapia en la hipertensión arterial

Pharmaceutical Care Espana

Volumn 6, Issue 3, 2004, Pages 119-126

  Huetos Ruiz, Jaime ^a  

^a Farmacia Ruiz Herraiz e Hijo C B ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35648960535     PISSN: None     EISSN: 11396202     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. U.S. Department of Health and Human services, National Herat, Lung, and Blood Institute. National Higth Blood Pressure Education Program. Avalaible at: http://www.nhlbi.nih.gov/about/nhbpep/index.htm. Accesed March 5, 2003.
2. Grupos de trabajo en hipertensión. Situación actual de la detección, tratamiento y control de la hipertensión arterial en España. Madrid; Liga española para la lucha contra la Hipertensión arterial, 1995; 47-61.
3. Kannel WB, Stokes J. Hipertension as a cardiovascular risk factor. En: Birkenhagen WH, Reid JL, editors. Handbook of hypertension. Epydemiology of hypertension. Amsterdam: Elsevier, 1985; 6: 15-34.
4. Badia X, Rovira J, Tresserras R, Trinxet C, Segu J, Pardell H. El coste de la hipertensión arterial en España. Med Clin (Barc) 1992; 99: 769-773.
5. Grupos de trabajo en hipertensión. Monitorización ambulatoria de la presion arterial. Madrid: Liga española para la lucha contra la hipertensión arterial, 1993.
6. O'Brein E, Scheridan J, O'Malley K: Dippers and non-dippers. Lancet 1998; 2: 397.
7. Benhorin J, Banal S, Moriel M, et al. Circadian variations in ischemic threshold and their relation to the occurrence of ischemic episodies. Circulation 1987; 87: 808-814.
8. Verdecchia P, Gotteschi C, Benemio G, Boldini F, Guerreri M, Porcellati C: Circadian blood pressure changes and left ventriculary hypertrophy in essential hypertension. Circulation 1990; 81: 528-536. (Pubitemid 20055961)
9. Schimada K, Kawamoto A, Matsubayashi M, Nishinaga M; Kimura S, Ozawa T: Diurnal blood pressure variations and silent cerebrovascular damage in ederly patiens with hypertension. J Hypertens 1992: 10: 875-878.
10. O'Brein E, Scheridan J, O'Malley K: Dippers and non-dippers. Lancet 1998; 2: 397.
11. Khoury AF, Sunderajan P, Kaplan N. The early morning rise in blood pressure is related mainly to ambulation. Am J Hypertension 1192; 5:339-334.
12. Mora J, Ocon J. Variabilidad de la presión arterial. Hipertensión 1987; 4: 387-394.
13. Swoyer J, Irvine P, Sachett-Lundeen L, Cnlin L, Lakatua DJ, Haus E. Circadian hematologyc time structure in the ederly. Chronobiol Int 1989; 168:467-517.
14. Willich SN, Linderer T, Wegcheider K, Schroder R and the ISAM Study Group: Increased risks of myocardial infarction in the morning (abstract). J Am Coll Cardiol 1988; 11:28A.
15. Gordon RD, Wolfe LK, Island DP and liiddle GW: A dyurnal rhythm in plasma renin activithy in man. J Clin Invest 1996; 45:1587-1592.
16. Galager TF, Yoshida K, Roffwarg HD, Fukushima DK, Weitzman ED, Hellman L: ACTH and cortisol secretory patteern in man. J Clin Encodrinol Metab 1973; 36: 1058-1073.
17. Mehta J, Malloy M, Lawson D, López L. Circadian variation in olatelet alpha2- adrenoceptor affinity in normal subjets. Am J Cardiol 1989; 63:1002-1005. (Pubitemid 19105147)
18. Palatini P, Raciappa A, Raule G, Zanimotto M, Penzo M, Pessina AC. Effect of timing of administration on the plasma ACE inhibitor activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther 1992; 52:378-383.
19. Pickering TG, Levenstein M, Walmsley P, for the hypertension and Lipid Trial Study Group. Nigjttime dosing of doxazosin haspeak effect on morning ambulatory blood pressure. Am J Hypertens 1994; 7: 844-847.
20. Kario K, Schimada K. Differential effects of alodipine on ambulatory blood pressure in the ederly hypertensive patiens with different nocturnal reductions in blood pressure. Am J Hypertens 1997; 10: 261-268.
21. Mallion JM, Lacourciere Y. Telmisartan blood pressure monitoring Group. A comparation of the blood pressure profile of the telmisartan and losartan at 18-24 hours posy-dosing as measured by ambulatory blood pressure monitoring (ABPM). 13th Scienti. Meeting of the American Society of Hypertension. New York. Am J Hypertens 1998; 11:4:262 (abstract).
22. García de Lucas MD, González Amieeva A, Trujillo Santos A J, López Alcalá E, Durán Izquierdo E, Martínez González S. Servicio de medicina interna. Hospital Comarcal Valle de los Pedroches. Pozoblanco. Córdoba.
23. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358:1305-15. (Pubitemid 33016494)
24. Guideliness subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17:151-83.
25. Guideliness subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17:151-83.
26. Hermida RC, Calvo C, Ayala DE, López JE, Fernández JR, Domínguez MJ, Martínez MC, Mojón A, Fontao MJ, Covelo M. Laboratorio de Bioingeniería y Cronobiología. Universidad de Vigo. Unidad de Hipertensión y Riesgo Vascular. Hospital Clínico Universitario. Santiago de Compostela.